Investment Opportunities in the South Korea Early Toxicity Testing Market South Korea Early Toxicity Testing Market is predicted to reach USD 115.53 million with a CAGR of 13.56% till 2030, according to new research by Next Move Strategy Consulting. The ongoing expansion of drug development pipelines by pharmaceutical companies in South Korea is a major driving force behind the early toxicity testing market's growth within South Korea. Discover the Full News : https://www.nextmsc.com/news/south-korea-early-toxicity-testing-market